Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · October 10, 2024

Outcomes of Conversion to Faricimab After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Oedema

The British Journal of Ophthalmology

 

Additional Info

The British Journal of Ophthalmology
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema
Br J Ophthalmol 2024 Aug 22;108(9)1257-1262, AF Durrani, B Momenaei, T Wakabayashi, S Vemula, SA Pandit, J Hsu, AC Ho, MJ Spirn, MA Klufas, SJ Garg, JF Vander, CD Regillo, A Chiang, AE Kuriyan, Y Yonekawa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading